Phaseline

Targets › GLOBOH

GLOBOH: drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 2; Oncology.

Open in Phaseline: the race on GLOBOH, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
OBI PharmaOBI-833/OBI-821
Globo H-targeting immunotherapy (cancer vaccine)
GLOBOHPhase 2Non-small Cell Lung Cancer–

Conditions

Non-small Cell Lung Cancer (1)

Modalities

mixed (1)

Companies

OBI Pharma (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.